Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia
Research article published in Journal of cardiothoracic and vascular anesthesia (2021)
Abstract
Herein the case of a patient with a prior history of heparin-induced thrombocytopenia who underwent percutaneous mitral valve edge-to-edge repair that was followed by a tricuspid edge-to-edge repair two months later is presented. Recommendations exist for systemic anticoagulant alternatives for percutaneous mitral valve edge-to-edge repair with the MitraClip device (Abbott, Chicago, IL), but minimal guidance and experience are present regarding alternative systemic anticoagulation during the performance of right-sided interventions, including tricuspid edge-to-edge repair (TriClip; Abbott). Notably, there is no clear consensus regarding the use of an alternative anticoagulant in the catheter flush solution for the delivery systems used during these procedures, particularly for right-sided interventions.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Резюме
Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia.
Почему это важно для гирудотерапии
This case report describes a patient with a prior history of heparin-induced thrombocytopenia who underwent a percutaneous mitral valve edge-to-edge repair followed by a tricuspid edge-to-edge repair two months later. The authors highlight the lack of established guidance and clinical experience regarding alternative systemic anticoagulation, as well as the lack of consensus on alternative anticoagulants in catheter flush solutions, particularly for right-sided interventions. The abstract does not specify which alternative anticoagulants were used or mention any connection to leeches, hirudin, or leech therapy. Therefore, this article has no defensible relevance to ASH's domain.
Цитирование
Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia
Colbaugh Z et al. · Journal of cardiothoracic and vascular anesthesia, 2021
Связанный клинический контекст
Узнайте, как это исследование связано с клинической практикой
Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026